213 related articles for article (PubMed ID: 10544085)
1. Minor displacements in the insertion site provoke major differences in the induction of antibody responses by chimeric parvovirus-like particles.
Rueda P; Hurtado A; del Barrio M; Martínez-Torrecuadrada JL; Kamstrup S; Leclerc C; Casal JI
Virology; 1999 Oct; 263(1):89-99. PubMed ID: 10544085
[TBL] [Abstract][Full Text] [Related]
2. Homogeneous processing and presentation of a recombined T cell epitope in inbred mice of different non-MHC genetic background.
Lo-Man R; Martineau P; Hofnung M; Leclerc C
Cell Immunol; 1996 Sep; 172(2):180-91. PubMed ID: 8964079
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity of poliovirus B and T cell epitopes presented by hybrid porcine parvovirus particles.
Sedlik C; Sarraseca J; Rueda P; Leclerc C; Casal I
J Gen Virol; 1995 Sep; 76 ( Pt 9)():2361-8. PubMed ID: 7561778
[TBL] [Abstract][Full Text] [Related]
4. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
Vietheer PT; Boo I; Drummer HE; Netter HJ
Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
[TBL] [Abstract][Full Text] [Related]
5. Chimeric parvovirus B19 capsids for the presentation of foreign epitopes.
Brown CS; Welling-Wester S; Feijlbrief M; Van Lent JW; Spaan WJ
Virology; 1994 Feb; 198(2):477-88. PubMed ID: 7507280
[TBL] [Abstract][Full Text] [Related]
6. Formation of immunogenic virus-like particles by inserting epitopes into surface-exposed regions of hamster polyomavirus major capsid protein.
Gedvilaite A; Frömmel C; Sasnauskas K; Micheel B; Ozel M; Behrsing O; Staniulis J; Jandrig B; Scherneck S; Ulrich R
Virology; 2000 Jul; 273(1):21-35. PubMed ID: 10891404
[TBL] [Abstract][Full Text] [Related]
7. Differences in the evolutionary pattern of feline panleukopenia virus and canine parvovirus.
Horiuchi M; Yamaguchi Y; Gojobori T; Mochizuki M; Nagasawa H; Toyoda Y; Ishiguro N; Shinagawa M
Virology; 1998 Sep; 249(2):440-52. PubMed ID: 9791034
[TBL] [Abstract][Full Text] [Related]
8. Generation of monoclonal antibodies of desired specificity using chimeric polyomavirus-derived virus-like particles.
Zvirbliene A; Samonskyte L; Gedvilaite A; Voronkova T; Ulrich R; Sasnauskas K
J Immunol Methods; 2006 Apr; 311(1-2):57-70. PubMed ID: 16516908
[TBL] [Abstract][Full Text] [Related]
9. Use of parvovirus-like particles for vaccination and induction of multiple immune responses.
Casal JI
Biotechnol Appl Biochem; 1999 Apr; 29(2):141-50. PubMed ID: 10075910
[TBL] [Abstract][Full Text] [Related]
10. Display of neutralizing epitopes of Canine parvovirus and a T-cell epitope of the fusion protein of Canine distemper virus on chimeric tymovirus-like particles and its use as a vaccine candidate both against Canine parvo and Canine distemper.
Chandran D; Shahana PV; Rani GS; Sugumar P; Shankar CR; Srinivasan VA
Vaccine; 2009 Dec; 28(1):132-9. PubMed ID: 19818723
[TBL] [Abstract][Full Text] [Related]
11. Control by Ig genes of the responsiveness to a neutralization viral B cell epitope.
Leclerc C; Martineau P; Charlot B; Delpeyroux F; van der Werf S; Hofnung M
J Immunol; 1997 Apr; 158(7):3252-8. PubMed ID: 9120281
[TBL] [Abstract][Full Text] [Related]
12. Delivery of a foreign epitope by sharing amino acid residues with the carrier matrix.
Cheong WS; Drummer HE; Netter HJ
J Virol Methods; 2009 Jun; 158(1-2):35-40. PubMed ID: 19189849
[TBL] [Abstract][Full Text] [Related]
13. Infectious bursal disease subviral particles displaying the foot-and-mouth disease virus major antigenic site.
Rémond M; Da Costa B; Riffault S; Parida S; Breard E; Lebreton F; Zientara S; Delmas B
Vaccine; 2009 Jan; 27(1):93-8. PubMed ID: 18983883
[TBL] [Abstract][Full Text] [Related]
14. The use of a monoclonal antibody and of DNA recombinant technology for the localization of a poliovirus neutralization epitope in viral capsid polypeptide VP1.
Bruneau P; van der Werf S; Wychowski C; Siffert O; Girard M
Dev Biol Stand; 1984; 57():177-85. PubMed ID: 6084609
[TBL] [Abstract][Full Text] [Related]
15. Multi-immunogenic outer membrane vesicles derived from an MsbB-deficient Salmonella enterica serovar typhimurium mutant.
Lee SR; Kim SH; Jeong KJ; Kim KS; Kim YH; Kim SJ; Kim E; Kim JW; Chang KT
J Microbiol Biotechnol; 2009 Oct; 19(10):1271-9. PubMed ID: 19884791
[TBL] [Abstract][Full Text] [Related]
16. Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface.
Rosenfeld SJ; Yoshimoto K; Kajigaya S; Anderson S; Young NS; Field A; Warrener P; Bansal G; Collett MS
J Clin Invest; 1992 Jun; 89(6):2023-9. PubMed ID: 1376332
[TBL] [Abstract][Full Text] [Related]
17. Epitope-specific antibody and suppression of autoantibody responses against a hybrid self protein.
Lohnas GL; Roberts SF; Pilon A; Tramontano A
J Immunol; 1998 Dec; 161(12):6518-25. PubMed ID: 9862676
[TBL] [Abstract][Full Text] [Related]
18. Development of a vaccine marker technology: display of B cell epitopes on the surface of recombinant polyomavirus-like pentamers and capsoids induces peptide-specific antibodies in piglets after vaccination.
Neugebauer M; Walders B; Brinkman M; Ruehland C; Schumacher T; Bertling WM; Geuther E; Reiser CO; Reichel C; Strich S; Hess J
Biotechnol J; 2006 Dec; 1(12):1435-46. PubMed ID: 17109492
[TBL] [Abstract][Full Text] [Related]
19. Two dominant neutralizing antigenic determinants of canine parvovirus are found on the threefold spike of the virus capsid.
Strassheim ML; Gruenberg A; Veijalainen P; Sgro JY; Parrish CR
Virology; 1994 Jan; 198(1):175-84. PubMed ID: 8259653
[TBL] [Abstract][Full Text] [Related]
20. Japanese encephalitis protein vaccine candidates expressing neutralizing epitope and M.T hsp70 induce virus-specific memory B cells and long-lasting antibodies in swine.
Fei-fei G; Jian W; Feng X; Li-ping S; Quan-yun S; Jin-ping Z; Pu-yan C; Pei-hong L
Vaccine; 2008 Oct; 26(44):5590-4. PubMed ID: 18761388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
